Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

«Sans patrie dans le monde»: Pellegrino Rossi o l’itinerario europeo di un universitario bolognese (1787-1848)

Autor: Elena Musiani

Il saggio si propone di seguire, dall’Italia alla Svizzera, fino alla Francia di François Guizot, l’itinerario europeo di Pellegrino Rossi, giurista, che fu studente e poi professore all’Università di Bologna. Il suo fu il percorso di un inte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4094::17a22de5cf022a24c1a66fb0b988896a
http://hdl.handle.net/11585/729809

Rare connective tissue diseases in patients with C1-inhibitor deficiency hereditary angioedema: first evidence on prevalence and distribution from a large Italian cohort study.

Autor: Triggianese, P., Senter, R., Perego, F., Gidaro, A., Petraroli, A., Arcoleo, F., Brussino, L., Giardino, F., Rossi, O., Bignardi, D., Quattrocchi, P., Brancaccio, R., Marcelli, A. Cesoni, Accardo, P. A., Lo Sardo, L., Cataudella, E., Guarino, M. D., Firinu, D., Bergamini, A., Spadaro, G.

Publikováno v: Frontiers in Immunology; 2024, p1-8, 8p

Cancer et pluralisme thérapeutique, de P. Cohen, A. Sarradon-Eck, I. Rossi, O. Schmitz et E. Legrand, Compte-rendu de lecture (avec Zoé Rollin)

Autor: Derbez, Benjamin

Publikováno v: Revue française de sociologie
Revue française de sociologie, Presse de Sciences Po / Centre National de la Recherche Scientifique, 2017, vol. 2 (58), pp.334-337

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::41dfa012a2b8dd9bcd43162ff5002bb8
https://hal.univ-brest.fr/hal-02175981

Characterization of an IL-8 cleavage inhibition assay to determine the functionality of anti-SpyCEP antibodies in human sera.

Autor: Massai L; GSK Vaccines Institute for Global Health (GVGH), GSK Global Health Vaccines R&D, Via Fiorentina 1, 53100 Siena, Italy., Carducci M; GSK Vaccines Institute for Global Health (GVGH), GSK Global Health Vaccines R&D, Via Fiorentina 1, 53100 Siena, Italy., Rovetini L; GSK Vaccines Institute for Global Health (GVGH), GSK Global Health Vaccines R&D, Via Fiorentina 1, 53100 Siena, Italy., Paterson A; School of Medical Sciences and Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand., Whitcombe A; School of Medical Sciences and Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand., McGregor R; School of Medical Sciences and Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand., Lorenz N; School of Medical Sciences and Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand., Keeley AJ; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK; Vaccines and Immunity Theme, Medical Research Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, the Gambia; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK., de Silva TI; Vaccines and Immunity Theme, Medical Research Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, the Gambia; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK., Bennett J; School of Medical Sciences and Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand; Department of Public Health, University of Otago, Wellington, New Zealand., Berlanda Scorza F; GSK Vaccines Institute for Global Health (GVGH), GSK Global Health Vaccines R&D, Via Fiorentina 1, 53100 Siena, Italy., Iturriza M; GSK Vaccines Institute for Global Health (GVGH), GSK Global Health Vaccines R&D, Via Fiorentina 1, 53100 Siena, Italy., Moreland NJ; School of Medical Sciences and Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand., Moriel DG; GSK Vaccines Institute for Global Health (GVGH), GSK Global Health Vaccines R&D, Via Fiorentina 1, 53100 Siena, Italy., Rossi O; GSK Vaccines Institute for Global Health (GVGH), GSK Global Health Vaccines R&D, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: omar.x.rossi@gsk.com.

Publikováno v: Journal of immunological methods [J Immunol Methods] 2024 Dec 04; Vol. 536, pp. 113786. Date of Electronic Publication: 2024 Dec 04.